This course will cover all major aspects related to endometrial cancer and atypical hyperplasia, focusing on fertility and support in achieving a pregnancy.
Endometrial Carcinoma (EC) is the 6th most commonly diagnosed cancer in women worldwide. While not that common in premenopausal women, EC and its standard treatment of total hysterectomy with bilateral salpingo-oophorectomy drastically affect the quality of life of patients and create a challenge for oncologists, surgeons and fertility specialists.
The guideline on “fertility-sparing treatment for endometrial carcinoma” developed between ESHRE, ESGO and ESGE will be presented.
Doctors and professionals involved in the care of endometrial cancer patients, or those interested to learn more about the disease and fertility preservation in these patients.
The course activity aims to address both of the following aspects:
By the end of this campus course the participants:
The course brings together different disciplines and perspectives to discuss a patient population that is considered clinically challenging.
The official language of the course is English.
Share this page